Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Combined Cerebrolysin and Amantadine in Traumatic Brain Injury
NCT06052787Phase 3Completed
- Sponsor
- Ain Shams University
- Start
- Sep 2023
- Primary completion
- May 2025
- Modality
- Small Molecules, Native Peptides
- Countries
- 1
01
Overview
A Phase 3 trial of cerebrolysin, amantadine in traumatic brain injury (TBI), sponsored by Ain Shams University. Started Sep 2023; status: completed.
02
Drugs
cerebrolysinamantadine
03
Conditions
traumatic brain injury (TBI)
Beyond the preview
Go deeper on NCT06052787.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06052787.